文献速递免疫规划职业卫生

医护人员接种BNT162b2 mRNA新冠疫苗后抗SARS-CoV-2 S1特异性IgG抗体水平与不良事件的相关性

Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.
PubMed 文献 · Vaccine · 2021-12-03

这项观察性研究评估了61名医护人员在第二剂BNT162b2疫苗接种至少7天后报告的不良事件,并分析不良事件与抗SARS-CoV-2 IgG抗体水平的相关性。参与者中位年龄51.25岁,16名男性、45名女性;77%报告了不良事件,注射部位疼痛、疲劳和发热最常见。出现发热者平均抗体水平为19,387 AU/mL,显著高于无发热者的平均9,977 AU/mL(p < 0.001)。

要点

  • 61名医护人员接种两剂BNT162b2疫苗后,77%报告不良事件。
  • 注射部位疼痛、疲劳和发热是最常见的不良事件。
  • 出现发热者平均抗体水平19,387 AU/mL,显著高于无发热者的9,977 AU/mL(p < 0.001)。

核心结论

  • 接种BNT162b2疫苗后出现发热的医护人员抗SARS-CoV-2 IgG抗体水平显著高于无发热者,该发现与既往在COVID-19患者中观察到的发热者抗体水平较高的现象一致。

研究设计与样本

  • 观察性研究,纳入61名医护人员,在第二剂BNT162b2疫苗接种至少7天后评估报告的不良事件并检测抗SARS-CoV-2 IgG抗体水平。

主要发现

  • 参与者中位年龄51.25岁,16名男性、45名女性。
  • 77%的参与者报告不良事件(男性44%、女性84.5%)。
  • 注射部位疼痛、疲劳和发热是最常见症状。
  • 出现发热者平均抗体水平为19,387 AU/mL,无发热者平均为9,977 AU/mL,p < 0.001。

关键数值与推荐

  • 出现发热者平均抗体水平19,387 AU/mL vs 无发热者平均9,977 AU/mL(p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Currently approved anti-COVID-19 vaccines have been found to be safe and effective and almost 60% of Israeli residents are already vaccinated with BNT162b2 vaccine. This observational study was designed to evaluate the adverse events of vaccine reported by 61 healthcare workers at least 7 days after the 2nd vaccination, and to investigate the correlation of adverse events and anti-SARS-CoV-2 IgG antibody levels. The median participant's age was 51.25 years, 16 men and 45 women; 77% (44% of male and 84.5% of female participants) reported adverse events. Injection site pain, fatigue and fever were the most common symptoms, and significantly higher antibody levels (average 19,387 AU/mL) were found in participants who had fever compared to those who did not experience fever (average antibody levels of 9,977 AU/mL, p < 0.001). This finding corresponds to previous observations of higher anti-SARS-CoV-2 IgG antibody levels in COVID-19 patients presented with fever.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Izak M, Stoyanov E, Dezuraev K, et al. Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers. Vaccine. 2021. PMID: 34903375. doi:10.1016/j.vaccine.2021.11.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。